|
Volumn 4, Issue 7, 2015, Pages
|
Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo
a a a a a a a a a a a a a a |
Author keywords
ATPase; interferon; moyamoya disease; RNF213; transgenic mouse
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE;
ADENOSINE TRIPHOSPHATE;
ANGIOGENESIS INHIBITOR;
ANGIOGENIC FACTOR;
AUTACOID;
RNF213 PROTEIN, HUMAN;
RNF213 PROTEIN, MOUSE;
UBIQUITIN PROTEIN LIGASE;
ANGIOGENESIS;
ANIMAL;
BINDING COMPETITION;
BINDING SITE;
BRAIN ARTERY;
C57BL MOUSE;
CELL MOTION;
CELL PROLIFERATION;
COMPLICATION;
DISEASE MODEL;
DOSE RESPONSE;
DRUG EFFECTS;
ENDOTHELIUM CELL;
ENZYMOLOGY;
GENETIC PREDISPOSITION;
GENETIC TRANSFECTION;
GENETICS;
HEK293 CELL LINE;
HELA CELL LINE;
HUMAN;
HYDROLYSIS;
HYPOXIA;
METABOLISM;
MOYAMOYA DISEASE;
MUTATION;
PATHOPHYSIOLOGY;
PHENOTYPE;
PROTEIN MOTIF;
SMOOTH MUSCLE CELL;
TIME FACTOR;
TRANSGENIC MOUSE;
UMBILICAL VEIN ENDOTHELIAL CELL;
ADENOSINE TRIPHOSPHATASES;
ADENOSINE TRIPHOSPHATE;
AMINO ACID MOTIFS;
ANGIOGENESIS INDUCING AGENTS;
ANGIOGENESIS INHIBITORS;
ANIMALS;
BINDING SITES;
BINDING, COMPETITIVE;
CELL MOVEMENT;
CELL PROLIFERATION;
CEREBRAL ARTERIES;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIAL CELLS;
GENETIC PREDISPOSITION TO DISEASE;
HEK293 CELLS;
HELA CELLS;
HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS;
HUMANS;
HYDROLYSIS;
HYPOXIA;
INFLAMMATION MEDIATORS;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
MOYAMOYA DISEASE;
MUTATION;
MYOCYTES, SMOOTH MUSCLE;
NEOVASCULARIZATION, PHYSIOLOGIC;
PHENOTYPE;
TIME FACTORS;
TRANSFECTION;
UBIQUITIN-PROTEIN LIGASES;
|
EID: 85018214590
PISSN: None
EISSN: 20479980
Source Type: Journal
DOI: 10.1161/JAHA.115.002146 Document Type: Article |
Times cited : (111)
|
References (0)
|